Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
18
Number of overlapping holdings
9.0%
% of IBB's 218 holdings also in IBRN
47.4%
% of IBRN's 54 holdings also in IBB
Overlap by Weight
Sector Drift (IBB minus IBRN)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBB |
Weight in IBRN |
Overlap | |
|---|---|---|---|---|
 |
BIOGEN IDEC INC | 3.2% | 4.7% | 3.2% |
 |
ARGENX SE ADR | 1.9% | 4.5% | 1.9% |
|
NEUROCRINE BIOSCIENCES INC | 1.3% | 4.9% | 1.3% |
|
SAREPTA THERAPEUTICS INC | 1.2% | 4.8% | 1.2% |
|
INTRA-CELLULAR THERAPIES INC | 0.6% | 4.3% | 0.6% |
Position Highlights (Non-Overlapping Exposures)
IBB Overweight Relative to IBRN
|
AMGEN INC | 9.4% |
|
REGENERON PHARMACEUTICALS | 8.4% |
|
VERTEX PHARMACEUTICALS INC | 8.3% |
|
GILEAD SCIENCES INC | 7.6% |
|
IQVIA HOLDINGS INC | 4.2% |
|
MODERNA, INC. | 4.0% |
 |
METTLER-TOLEDO INTERNATIONAL | 3.2% |
|
WATERS CORP | 2.1% |
 |
BIONTECH SE SPONSORED ADR | 1.9% |
|
ALNYLAM PHARMACEUTICALS INC | 1.9% |
IBB Underweight Relative to IBRN
|
CEREVEL THERAPEUTICS HOLDINGS INC | -4.8% |
|
AXONICS MODULATION TECHNOLOGIES, INC | -4.7% |
|
PTC THERAPEUTICS INC | -4.5% |
 |
SK BIOPHARMACEUTICALS CO., LTD. | -3.8% |
|
INTRA-CELLULAR THERAPIES INC | -3.6% |
|
SAREPTA THERAPEUTICS INC | -3.6% |
|
NEUROCRINE BIOSCIENCES INC | -3.5% |
|
INTEGRA LIFESCIENCES HOLDING | -3.4% |
 |
ALKERMES PLC | -3.3% |
|
CATALYST PHARMACEUTICAL PART | -3.3% |